Dupixent CTCL MDL 3180: What the Transfer Order Means for Patients
What patients and families should know after Dupixent CTCL claims were centralized in MDL No. 3180 in New Jersey.
What patients and families should know after Dupixent CTCL claims were centralized in MDL No. 3180 in New Jersey.
A plain-English July 2026 update on Dupixent CTCL MDL 3180, what the JPML order says, and which records families should save now.
What families should know about Dupixent lawsuit reviews involving CTCL, recall questions, and the records that help establish the timeline.